Soleus Capital Management’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-139,512
Closed -$5.72M 101
2025
Q3
$5.72M Sell
139,512
-72,388
-34% -$2.96M 0.29% 58
2025
Q2
$9.05M Buy
+211,900
New +$7.39M 0.6% 42
2025
Q1
Sell
-59,400
Closed -$2.74M 83
2024
Q4
$2.74M Hold
59,400
0.17% 66
2024
Q3
$2.57M Buy
59,400
+44,400
+296% +$1.93M 0.2% 74
2024
Q2
$682K Buy
+15,000
New +$761K 0.06% 85
2023
Q1
Sell
-39,920
Closed -$2.62M 84
2022
Q4
$2.62M Sell
39,920
-22,700
-36% -$1.37M 0.38% 51
2022
Q3
$3.42M Sell
62,620
-15,780
-20% -$943K 0.46% 49
2022
Q2
$4.26M Buy
+78,400
New +$4.98M 0.67% 45
2021
Q3
Sell
-26,568
Closed -$2.32M 75
2021
Q2
$2.32M Sell
26,568
-34,583
-57% -$2.57M 0.36% 48
2021
Q1
$3.82M Sell
61,151
-5,770
-9% -$333K 0.69% 27
2020
Q4
$2.52M Buy
+66,921
New +$1.76M 0.33% 30
2020
Q2
Sell
-63,254
Closed -$914K 65
2020
Q1
$914K Sell
63,254
-30,306
-32% -$669K 1.06% 25
2019
Q4
$2.59M Buy
+93,560
New +$2.07M 2.5% 14

Other funds holding ESTA

Soleus Capital Management's ESTA Position: Q4 2025 in Review

Soleus Capital Management sold out of Establishment Labs (ESTA) in Q4 2025, closing a stake of 139,512 shares — an estimated $5.72M sold.

Soleus Capital Management first reported a position in ESTA in Q4 2019 and held it in 13 quarters. The position peaked at $9.05M in Q2 2025. 174 funds tracked by Wall St. Rank hold ESTA as of Q4 2025.

  • Soleus Capital Management reported no remaining Establishment Labs position as of Q4 2025 after selling out during the quarter.
  • Soleus Capital Management sold 139,512 Establishment Labs shares in Q4 2025, an estimated $5.72M.
  • Soleus Capital Management first reported a position in Establishment Labs in Q4 2019 and held it in 13 quarters.
  • Soleus Capital Management's Establishment Labs position peaked at $9.05M in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Establishment Labs as of Q4 2025.

Based on Soleus Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.